Person · CIK 1723524

Darren Sherman

Director at Orchestra BioMed Holdings

Earlier: Motus GI Holdings

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$634K
Noticed on Form 144$637K
Bought on Form 4$252K
Companies2

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Orchestra BioMed Holdings OBIOCommon Stock, par value $0.0001 per share ("Common Stock")Directly1,104,402Nov 2, 2026 · Filing · EDGAR
Orchestra BioMed Holdings OBIOCommon StockBy son2,000Nov 2, 2026 · Filing · EDGAR
Orchestra BioMed Holdings OBIOStock Option
exercise $2.85, expires Apr 23, 2035, into Common Stock
Directly34,974Jan 28, 2026 · Filing · EDGAR
Motus GI HoldingsCommon Stock, par value $0.0001 per shareDirectly194,602Jan 5, 2022 · Filing · EDGAR
Motus GI HoldingsCommon Stock, par value $0.0001 per shareBy Orchestra BioMed, Inc.2,051,498Jan 5, 2022 · Filing · EDGAR
Motus GI HoldingsCommon Stock, par value $0.0001 per shareBy Orchestra MOTUS Co-Investment Partners, LLC1,159,968May 31, 2018 · Filing · EDGAR
Motus GI HoldingsCommon Stock, par value $0.0001 per shareBy Orchestra Medical Ventures II, L.P.109,792May 31, 2018 · Filing · EDGAR
Motus GI HoldingsCommon Stock, par value $0.0001 per shareBy Orchestra Medical Ventures II Reserve, L.P.83,352May 31, 2018 · Filing · EDGAR
Motus GI HoldingsCommon Stock, par value $0.0001 per shareBy Accelerated Technologies, Inc.51,498Feb 6, 2020 · Filing · EDGAR
Motus GI HoldingsStock Option (right to buy)
exercise $0.46, expires Feb 10, 2032, into Common Stock, par value $0.0001 per share
Directly50,000Feb 10, 2022 · Filing · EDGAR

Sold and noticed by quarter

Darren Sherman: dollars sold on Form 4 and noticed on Form 144 per quarter, Q1 2021 to Q4 2026$201K$0Q1 2021: $0 noticed on Form 144Q1 2021: $0 sold on Form 4Q2 2021: $0 noticed on Form 144Q2 2021: $0 sold on Form 4Q3 2021: $0 noticed on Form 144Q3 2021: $0 sold on Form 4Q4 2021: $0 noticed on Form 144Q4 2021: $0 sold on Form 4Q1 2022: $0 noticed on Form 144Q1 2022: $0 sold on Form 4Q2 2022: $0 noticed on Form 144Q2 2022: $0 sold on Form 4Q3 2022: $0 noticed on Form 144Q3 2022: $0 sold on Form 4Q4 2022: $0 noticed on Form 144Q4 2022: $0 sold on Form 4Q1 2023: $0 noticed on Form 144Q1 2023: $0 sold on Form 4Q2 2023: $0 noticed on Form 144Q2 2023: $0 sold on Form 4Q3 2023: $0 noticed on Form 144Q3 2023: $0 sold on Form 4Q4 2023: $0 noticed on Form 144Q4 2023: $0 sold on Form 4Q1 2024: $0 noticed on Form 144Q1 2024: $0 sold on Form 4Q2 2024: $0 noticed on Form 144Q2 2024: $0 sold on Form 4Q3 2024: $195K noticed on Form 144Q3 2024: $195K sold on Form 4Q4 2024: $0 noticed on Form 144Q4 2024: $0 sold on Form 4Q1 2025: $0 noticed on Form 144Q1 2025: $0 sold on Form 4Q2 2025: $0 noticed on Form 144Q2 2025: $0 sold on Form 4Q3 2025: $0 noticed on Form 144Q3 2025: $0 sold on Form 4Q3 2025: $8K boughtQ4 2025: $0 noticed on Form 144Q4 2025: $0 sold on Form 4Q1 2026: $0 noticed on Form 144Q1 2026: $0 sold on Form 4Q2 2026: $58K noticed on Form 144Q2 2026: $58K sold on Form 4Q3 2026: $201K noticed on Form 144Q3 2026: $200K sold on Form 4Q3 2026: $11K boughtQ4 2026: $183K noticed on Form 144Q4 2026: $182K sold on Form 4Q1 2021Q2 2022Q3 2023Q4 2024Q1 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)Bought (Form 4)
Q4 2026$182K$183K—
Q3 2026$200K$201K$11K
Q2 2026$58K$58K—
Q3 2025——$8K
Q3 2024$195K$195K—
Q4 2020——$3K
Q2 2018——$6K
Q1 2018——$225K

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
Orchestra BioMed Holdings OBIO · Fidelity Brokerage Services · 10b5-1 plan adopted Dec 18, 2025 · 6 notices
Nov 2, 202615,000 · ~$89KNov 2, 2026Sold as noticed Sold 15,000 at $5.74 on Nov 2 · $86K Form 4Filing · EDGAR
Oct 1, 202615,000 · ~$94KOct 1, 2026Sold as noticed Sold 15,000 at $6.36 on Oct 1 · $95K Form 4Filing · EDGAR
Sep 1, 202615,000 · ~$75KSep 1, 2026Sold as noticed Sold 15,000 at $4.94 on Sep 1 · $74K Form 4Filing · EDGAR
Aug 3, 202615,000 · ~$61KAug 3, 2026Sold as noticed Sold 15,000 at $4.09 on Aug 3 · $61K Form 4Filing · EDGAR
Jul 1, 202615,000 · ~$65KJul 1, 2026Sold as noticed Sold 15,000 at $4.27 on Jul 1 · $64K Form 4Filing · EDGAR
Jun 1, 202615,000 · ~$58KJun 1, 2026Sold as noticed Sold 15,000 at $3.87 on Jun 1 · $58K Form 4Filing · EDGAR
Orchestra BioMed Holdings OBIO · Fidelity Brokerage Services · No 10b5-1 plan stated · 5 notices
Sep 10, 20246,904 · ~$37KSep 10, 2024Sold as noticed Sold 6,904 at $5.31 on Sep 10 · $37K Form 4Filing · EDGAR
Sep 9, 20246,804 · ~$37KSep 9, 2024Sold as noticed Sold 6,804 at $5.48 on Sep 9 · $37K Form 4Filing · EDGAR
Sep 6, 20246,819 · ~$39KSep 6, 2024Sold as noticed Sold 6,819 at $5.65 on Sep 6 · $39K Form 4Filing · EDGAR
Sep 5, 20246,961 · ~$41KSep 5, 2024Sold as noticed Sold 6,961 at $5.85 on Sep 5 · $41K Form 4Filing · EDGAR
Sep 4, 20246,837 · ~$42KSep 4, 2024Sold as noticed Sold 6,837 at $6.10 on Sep 4 · $42K Form 4Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Orchestra BioMed Holdings OBIO Director, Officer · filings 2023 to 2026 · sold $634K · bought $19K · $637K noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Nov 2, 2026Sale under a 10b5-1 plan−15,000$5.74$86K1,104,402 directFiling · EDGAR
Oct 1, 2026Sale under a 10b5-1 plan−15,000$6.36$95K1,119,402 directFiling · EDGAR
Sep 1, 2026Sale under a 10b5-1 plan−15,000$4.94$74K1,134,402 directFiling · EDGAR
Aug 26, 2026Shares withheld for tax or exercise price−4,925$5.26$26K1,149,402 directFiling · EDGAR
Aug 26, 2026Open-market or private purchase+2,000$5.33$11K2,000
By son
Filing · EDGAR
Aug 3, 2026Sale under a 10b5-1 plan−15,000$4.09$61K1,154,327 directFiling · EDGAR
Jul 1, 2026Sale under a 10b5-1 plan−15,000$4.27$64K1,169,327 directFiling · EDGAR
Jun 1, 2026Sale under a 10b5-1 plan−15,000$3.87$58K1,184,327 directFiling · EDGAR
May 28, 2026Shares withheld for tax or exercise price−4,925$3.98$20K1,199,327 directFiling · EDGAR
Mar 25, 2026Shares withheld for tax or exercise price−33,317$4.57$152K1,204,252 directFiling · EDGAR
Feb 12, 2026Grant or award from the company+397,0001,237,569 directFiling · EDGAR
Jan 28, 2026Grant or award from the company
Stock Option
+34,97434,974 directFiling · EDGAR
Jan 2, 2026Shares withheld for tax or exercise price−5,588$4.31$24K840,569 directFiling · EDGAR
Nov 25, 2025Shares withheld for tax or exercise price−40,340$5.35$216K846,157 directFiling · EDGAR
Sep 3, 2025Shares withheld for tax or exercise price−40,340$2.72$110K886,497 directFiling · EDGAR
Aug 25, 2025Open-market or private purchase+3,000$2.62$8K926,837 directFiling · EDGAR
Aug 7, 2025Grant or award from the company+120,000923,837 directFiling · EDGAR
May 28, 2025Shares withheld for tax or exercise price−45,843$2.95$135K803,837 directFiling · EDGAR
Apr 4, 2025Grant or award from the company+115,708849,680 directFiling · EDGAR
Dec 5, 2024Shares withheld for tax or exercise price−31,815$5.57$177K733,972 directFiling · EDGAR
Sep 10, 2024Open-market or private sale−6,904$5.31$37K765,787 directFiling · EDGAR
Sep 9, 2024Open-market or private sale−6,804$5.48$37K772,691 directFiling · EDGAR
Sep 6, 2024Open-market or private sale−6,819$5.65$39K779,495 directFiling · EDGAR
Sep 5, 2024Open-market or private sale−6,961$5.85$41K786,314 directFiling · EDGAR
Sep 4, 2024Open-market or private sale−6,837$6.10$42K793,275 directFiling · EDGAR
May 8, 2024Grant or award from the company+176,667800,112 directFiling · EDGAR
Jul 20, 2023Grant or award from the company+539,667623,445 directFiling · EDGAR
Apr 12, 2023Option or RSU exercised or converted+14,959$15.00$224K83,778 directFiling · EDGAR
Apr 12, 2023Option or RSU exercised or converted
Right to Receive Earnout Shares
−14,95914,959 directFiling · EDGAR
Jan 26, 2023Grant or award from the company
Nonstatutory Stock Option (Right to Buy)
+508,397508,397 directFiling · EDGAR
Jan 26, 2023Grant or award from the company
Nonstatutory Stock Option (Right to Buy)
+116,250116,250 directFiling · EDGAR
Jan 26, 2023Grant or award from the company+68,81968,819 directFiling · EDGAR
Jan 26, 2023Grant or award from the company
Right to Receive Earnout Shares
+29,91829,918 directFiling · EDGAR
Jan 26, 2023Grant or award from the company
Incentive Stock Option (Right to Buy)
+6,7436,743 directFiling · EDGAR

Motus GI Holdings Director · filings 2018 to 2022 · bought $233K

DateTransactionSharesPriceValueHeld afterSource
Feb 10, 2022Grant or award from the company
Stock Option (right to buy)
+50,00050,000 directFiling · EDGAR
Jan 5, 2022Grant or award from the company+90,521194,602 directFiling · EDGAR
Feb 17, 2021Grant or award from the company+30,00081,890 directFiling · EDGAR
Feb 17, 2021Grant or award from the company+22,191104,081 directFiling · EDGAR
Feb 17, 2021Grant or award from the company
Stock Option (right to buy)
+30,00030,000 directFiling · EDGAR
Jan 12, 2021Grant or award from the company+9,14451,890 directFiling · EDGAR
Dec 17, 2020Open-market or private purchase+3,000$0.97$3K42,746 directFiling · EDGAR
Oct 12, 2020Grant or award from the company+10,34639,746 directFiling · EDGAR
Jul 10, 2020Grant or award from the company+7,90029,400 directFiling · EDGAR
Feb 6, 2020Grant or award from the company+12,50021,500 directFiling · EDGAR
Feb 6, 2020Grant or award from the company
Stock Option (right to buy)
+12,50012,500 directFiling · EDGAR
Feb 13, 2019Grant or award from the company
Stock Option (right to buy)
+25,00025,000 directFiling · EDGAR
May 31, 2018Other acquisition or disposition (see the filing)−1,000,000109,792
By Orchestra Medical Ventures II, L.P.
Filing · EDGAR
May 31, 2018Other acquisition or disposition (see the filing)+2,000,0002,000,000
By Orchestra BioMed, Inc.
Filing · EDGAR
May 17, 2018Open-market or private purchase+1,000$5.55$6K9,000 directFiling · EDGAR
Feb 16, 2018Open-market or private purchase+5,000$5.00$25K7,250 directFiling · EDGAR
Feb 16, 2018Derivative converted+7508,000 directFiling · EDGAR
Feb 16, 2018Open-market or private purchase+40,000$5.00$200K1,010,044
By Orchestra Medical Ventures II, L.P.
Filing · EDGAR
Feb 16, 2018Derivative converted+99,7481,109,792
By Orchestra Medical Ventures II, L.P.
Filing · EDGAR
Feb 16, 2018Derivative converted+65,0381,159,968
By Orchestra MOTUS Co-Investment Partners, LLC
Filing · EDGAR
Feb 16, 2018Derivative converted
Series A Convertible Preferred Stock
−7500 directFiling · EDGAR
Feb 16, 2018Derivative converted
Series A Convertible Preferred Stock
−99,7480
By Orchestra Medical Ventures II, L.P.
Filing · EDGAR
Feb 16, 2018Derivative converted
Series A Convertible Preferred Stock
−65,0380
By Orchestra MOTUS Co-Investment Partners, LLC
Filing · EDGAR
Feb 16, 2018Other acquisition or disposition (see the filing)
Warrants (right to buy)
+300300 directFiling · EDGAR
Feb 16, 2018Other acquisition or disposition (see the filing)
Warrants (right to buy)
+106,980106,980
By Orchestra Medical Ventures II, L.P.
Filing · EDGAR
Feb 16, 2018Other acquisition or disposition (see the filing)
Warrants (right to buy)
+115,997115,997
By Orchestra MOTUS Co-Investment Partners, LLC
Filing · EDGAR
All 53 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Nov 3, 2026Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Nov 2, 2026Form 144Orchestra BioMed Holdings OBIOFiling · EDGAR
Oct 2, 2026Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Oct 1, 2026Form 144Orchestra BioMed Holdings OBIOFiling · EDGAR
Sep 2, 2026Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Sep 1, 2026Form 144Orchestra BioMed Holdings OBIOFiling · EDGAR
Aug 28, 2026Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Aug 4, 2026Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Aug 3, 2026Form 144Orchestra BioMed Holdings OBIOFiling · EDGAR
Jul 2, 2026Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Jul 1, 2026Form 144Orchestra BioMed Holdings OBIOFiling · EDGAR
Jun 2, 2026Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Jun 1, 2026Form 144Orchestra BioMed Holdings OBIOFiling · EDGAR
May 29, 2026Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Mar 27, 2026Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Feb 13, 2026Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Feb 6, 2026Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Jan 2, 2026Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Nov 26, 2025Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Sep 5, 2025Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Aug 25, 2025Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Aug 8, 2025Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
May 30, 2025Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Apr 4, 2025Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Dec 6, 2024Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Sep 10, 2024Form 144Orchestra BioMed Holdings OBIOFiling · EDGAR
Sep 10, 2024Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Sep 9, 2024Form 144Orchestra BioMed Holdings OBIOFiling · EDGAR
Sep 6, 2024Form 144Orchestra BioMed Holdings OBIOFiling · EDGAR
Sep 6, 2024Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Sep 5, 2024Form 144Orchestra BioMed Holdings OBIOFiling · EDGAR
Sep 4, 2024Form 144Orchestra BioMed Holdings OBIOFiling · EDGAR
May 10, 2024Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Jul 24, 2023Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
May 19, 2023Form 4/AOrchestra BioMed Holdings OBIOFiling · EDGAR
May 5, 2023Form 4/AOrchestra BioMed Holdings OBIOFiling · EDGAR
May 5, 2023Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Jan 30, 2023Form 4Orchestra BioMed Holdings OBIOFiling · EDGAR
Jan 30, 2023Form 3Orchestra BioMed Holdings OBIOFiling · EDGAR
Feb 11, 2022Form 4Motus GI HoldingsFiling · EDGAR
Jan 7, 2022Form 4Motus GI HoldingsFiling · EDGAR
Feb 19, 2021Form 4Motus GI HoldingsFiling · EDGAR
Jan 14, 2021Form 4Motus GI HoldingsFiling · EDGAR
Dec 18, 2020Form 4Motus GI HoldingsFiling · EDGAR
Oct 13, 2020Form 4Motus GI HoldingsFiling · EDGAR
Jul 13, 2020Form 4Motus GI HoldingsFiling · EDGAR
Feb 7, 2020Form 4Motus GI HoldingsFiling · EDGAR
Feb 15, 2019Form 4Motus GI HoldingsFiling · EDGAR
Jun 4, 2018Form 4Motus GI HoldingsFiling · EDGAR
May 21, 2018Form 4Motus GI HoldingsFiling · EDGAR
Feb 21, 2018Form 4Motus GI HoldingsFiling · EDGAR
Feb 21, 2018Form 3/AMotus GI HoldingsFiling · EDGAR
Feb 13, 2018Form 3Motus GI HoldingsFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.